DECHRA VETERINARY PRODUCTS A/S: Financial statements 2014
CVR: 10114241
Source: annual report 2014, Danish Business Authority
01/07/2013 – 30/06/2014
DECHRA VETERINARY PRODUCTS A/S (CVR 10114241) has filed annual accounts for 2014. In 2014, the company reported revenue of DKK 731,717,000 and a net result of DKK 61,395,000 compared with DKK 67,790,000 the year before. That is an increase of 5% compared with the year before. The profit margin was 8.4%. Equity in the 2014 report amounted to DKK 460,095,000. The solvency ratio was 77.9%. The company had 233 employees in the financial year.
- Revenue
- DKK 731,717,000
- Gross Profit
- DKK 126,348,000
- Profit/Loss
- DKK 61,395,000
- Equity
- DKK 460,095,000
- Total Assets
- DKK 590,777,000
- Employees
- 233
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | 731.7M | 126.3M | 61.4M | 460.1M | 233 |
| 2013 | 697M | 186.1M | 67.8M | 397.9M | 214 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of December 19, 2014, KPMG P/S has been appointed auditor of DECHRA VETERINARY PRODUCTS A/S.
As of December 19, 2014, EY Godkendt Revisionspartnerselskab has stepped down as auditor of DECHRA VETERINARY PRODUCTS A/S.
About DECHRA VETERINARY PRODUCTS A/S
DECHRA VETERINARY PRODUCTS A/S is a Danish company of the type Aktieselskab based in Uldum, founded in 1986. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETXX A/S and LEO ANIMAL HEALTH A/S. The management consists of Ian Machan Mackellar. The board consists of Ajay Gandhi (chair), Ian Machan Mackellar and Robert Mark Leather. The company is owned by Dechra Pharmaceuticals Limited. The company has 122 employees (2026). In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. Equity in the 2025 report amounted to DKK 571,636,000.